|
Glioblastoma / Treatment
|
|
Flavopiridol
|
|
Home >
Database > Glioblastoma
> Treatment
>
Flavopiridol
|
|
|
Contents
|
|
|
|
|
|
|
|
Overviews
|
|
|
|
|
|
|
|
Laboratory
Investigations
|
|
|
|
|
Newcomb EW, Lymberis SC, Lukyanov Y, Shao Y, Schnee T, Devitt M, Rosenstein BS,
Zagzag D, Formenti SC
Radiation sensitivity of GL261 murine glioma model and enhanced radiation
response by flavopiridol
Cell Cycle.
2006 Jan 1; 5(1):93-9
.JPG) Abstract | .png) Reprint
|
|
|
Newcomb EW, Tamasdan C, Entzminger Y, Arena E, Schnee T, Kim M, Crisan D, Lukyanov
Y, Miller DC, Zagzag D
Flavopiridol inhibits the growth of GL261 gliomas in vivo: implications for
malignant glioma therapy
Cell Cycle.
2004 Feb;3(2):230-4
Abstract |
Reprint
|
|
|
Clinical
Investigations
|
|
|
|
|
|
|
|
First-diagnosis
Tumors
|
|
|
|
|
|
|
|
Recurrent
Tumors
|
|
|
|
|
|
|
|
Elderly
Patients
|
|
|
|
|
|
|
|
Pediatric
Patients
|
|
|
|
|
|
|
|
Case
Reports
|
|
|
|
|
|
|
|
Complications
|
|
|
|
|
|
|
|
Survival
|
|
|
|
|
|
|
